The long voyage to acceptance for the brain’s primary neurotransmitters
A new personal account in the Journal of Neurochemistry details the 65-year scientific journey that established glutamate and GABA as the central nervous system’s principal excitatory and inhibitory neurotransmitters. The historical review, authored by a key researcher in the field, chronicles the initial prejudice and methodological hurdles that delayed acceptance, followed by pivotal discoveries in neurotransmitter localization, synaptic vesicle concentration, and the molecular identification of critical transporters and receptors. This narrative underscores how foundational neurobiology research on neural circuits, synaptic plasticity, and neurochemical pathways paved the way for modern investigations into their roles in neurodegeneration, epilepsy, and neuropsychiatric disorders.
Study Significance: Understanding the historical context of these fundamental discoveries provides crucial perspective for current research into neurological disorders linked to glutamate and GABA dysfunction, such as Alzheimer’s disease, stroke, and epilepsy. For neurologists and neuroscientists, this account reinforces the importance of precise neurotransmitter system mapping for developing targeted therapies and informs ongoing exploration of these pathways in cognitive impairment and movement disorders.
Source →Stay curious. Stay informed — with Science Briefing.
This is a one time Briefing, Upgrade to continue.
Upgrade and get 50% Off — Coupon: ERWMCWYU
